- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01068405
Erosive Osteoarthritis of the Hands: Treatment by Methotrexate Versus Placebo (ADEM)
Erosive Osteoarthritis of the Hands: Treatment by Methotrexate Versus Placebo - Assessment of Structural and Clinical Action of Magnetic Resonance Imaging
Interest of methotrexate in inflammatory rheumatisms was demonstrated since several years.
At present time,there is no effective treatment against digital arthritis. The investigators purpose to measure the efficacy of methotrexate on digital arthritis.
In this aim, two groups were compared. The first group receive 10mg/week of methotrexate administered in one shot (every Monday for example)during 12 months. The second group receive 10mg/week of placebo according to the same procedure
Study Overview
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Contact
- Name: Christian H ROUX, PhD
- Email: roux.cr@chu-nice.fr
Study Locations
-
-
-
Nice, France, 06000
- Recruiting
- Nice University Hospital, Rheumatology Department
-
Contact:
- Christian H ROUX, PhD
- Phone Number: 0492035491
- Email: roux.cr@chu-nice.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- hand arthritis
- pain over 40/100
- stable treatment since 4 weeks at least with non-steroid analgesic
- between 45 et 85 years
Exclusion Criteria:
- pregnancy or breast feeding women
- hyaluronic acid injection within the past 6 months
- cortisonic derivated injection within the past 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Methotrexate
Patients with digital arthritis receiving methotrexate treatment at 10mg/week during 12 months
|
Methotrexate: 10mg/week administered in one time, the same day each week (every monday for example)during 12 months
|
Placebo Comparator: Placebo
Patients with digital arthritis receiving placebo at 10mg/week during 12 months
|
Placebo:10mg/week administered in one time, the same day each week (every monday for example)during 12 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
pain assessed with EVA
Time Frame: at screening visit, inclusion visit, first month, and every month during one year
|
at screening visit, inclusion visit, first month, and every month during one year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Quality of life survey : SF-36
Time Frame: at inclusion visit, first month, and every month during one year
|
at inclusion visit, first month, and every month during one year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Christian H ROUX, PhD, Nice University Hospital
Publications and helpful links
General Publications
- Ferrero S, Wittoek R, Allado E, Cruzel C, Fontas E, Breuil V, Ziegler L, Kremer J, Loeuille D, Roux CH. Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial. Semin Arthritis Rheum. 2021 Aug;51(4):831-838. doi: 10.1016/j.semarthrit.2021.04.016. Epub 2021 May 6.
- Allado E, Wittoek R, Albuisson E, Ferrero S, Chenuel B, Chary-Valckenaere I, Roux C, Loeuille D. Topographical analysis of structural lesions between dominant and non-dominant hands in erosive osteoarthritis. Rheumatol Int. 2021 Mar;41(3):617-623. doi: 10.1007/s00296-020-04784-1. Epub 2021 Jan 27.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Joint Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases
- Arthritis
- Osteoarthritis
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Nucleic Acid Synthesis Inhibitors
- Enzyme Inhibitors
- Antirheumatic Agents
- Antimetabolites, Antineoplastic
- Antimetabolites
- Antineoplastic Agents
- Immunosuppressive Agents
- Immunologic Factors
- Dermatologic Agents
- Reproductive Control Agents
- Abortifacient Agents, Nonsteroidal
- Abortifacient Agents
- Folic Acid Antagonists
- Methotrexate
Other Study ID Numbers
- 06-API-07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polyarthritis
-
Centre Hospitalier Universitaire de NīmesRecruitingRheumatoid PolyarthritisFrance
-
CEN BiotechMYEXPRESIONRecruitingPolyarthritis; RheumatoidFrance
-
BADOT, ValerieUnknownRheumatoid PolyarthritisBelgium
-
Centre Hospitalier Universitaire, AmiensUnknownMethotrexate | Polyarthritis; RheumatoidFrance
-
University Hospital, BrestCompletedCrystal-Induced ArthritisFrance
-
Uppsala UniversityUnknownArthritis of the KneeSweden
-
Norwegian University of Science and TechnologyThe Research Council of NorwayCompleted
-
Laval UniversityMinistry of Agriculture, Fisheries and Food, Quebec; Groupe De Recherche En...Recruiting
-
Zimmer BiometCompletedOsteoarthritis | Traumatic Arthritis | Polyarthritis | RheumatoId ArthritisUnited States
-
Medacta International SARecruitingArthrosis | Congenital Hip Dysplasia | Traumatic Arthritis | Rheumatoid Polyarthritis | Avascular Necrosis of the Femoral HeadAustria, Italy, Switzerland, United Kingdom
Clinical Trials on Methotrexate
-
University Hospital, MontpellierPfizer; Hôpital CochinCompletedRheumatoid ArthritisFrance, Monaco
-
Nicolaus Copernicus UniversityCompleted
-
Amneal Pharmaceuticals, LLCAccutest Research Laboratories (I) Pvt. Ltd.Unknown
-
Hee Young JuNot yet recruitingLymphoblastic Leukemia in Children
-
PfizerCompletedRheumatoid ArthritisUnited States, Mexico, Argentina, Chile, Croatia, Czech Republic, Hungary, Poland, Puerto Rico
-
PfizerCompletedRhematoid ArthritisSpain, United Kingdom, United States, Korea, Republic of, Poland, Israel, Australia, Taiwan, Thailand, South Africa, Bulgaria, Estonia, Latvia, Philippines, Canada, Romania, Russian Federation, Turkey, Mexico, Bosnia and Herzegovina and more
-
Cairo UniversityCompleted
-
Chugai Pharma TaiwanCompletedRheumatoid Arthritis (RA)Taiwan
-
CHA UniversityCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted